ProMetic Life Sciences Inc.
TSX : PLI.SV

ProMetic Life Sciences Inc.

October 25, 2005 13:15 ET

CORRECTION FROM SOURCE/ProMetic Life Sciences Inc. to Present at Rodman & Renshaw Techvest 7th Annual Healthcare Conference in New York

MONTREAL, QUEBEC--(CCNMatthews - Oct. 25, 2005) -

An error occurred in the press release sent earlier today. The presentation is scheduled for 12:40 pm NOT FOR 12:40 am Eastern Time on Wednesday, November 9, 2005. A complete and corrected version follows:

ProMetic Life Sciences Inc. (TSX:PLI.SV) today announced that Pierre Laurin, Chairman, President and CEO will be presenting at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference. The presentation is scheduled for 12:40 pm Eastern Time on Wednesday, November 9, 2005 at the New York Palace Hotel, located at 455 Madison Avenue in New York City. The presentation will be available as a live audio web cast at http://wsw.com/webcast/rrshq7/pli.sv.to/. A replay of the presentation will be available for 90 days at the aforementioned URL.

About ProMetic Life Sciences

ProMetic Life Sciences Inc. is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand™ enabling technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of inflammation and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D and manufacturing facilities in the UK and business development activities in the US, Europe, Asia and MENA countries (Middle East and North Africa).

Additional information is available on the Company's website at www.prometic.com.

Contact Information